| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/17425240903405581 |
| P8608 | Fatcat ID | release_2hl5pcyv6nf2vpcvd2zhsuisxq |
| P698 | PubMed publication ID | 20017662 |
| P2093 | author name string | Santosh Pasha | |
| Kshitij Gupta | |||
| P2860 | cites work | Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease | Q21262018 |
| In vivo protein transduction: delivery of a biologically active protein into the mouse | Q29615482 | ||
| Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice | Q31115814 | ||
| Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes | Q31821882 | ||
| Synthesis and characterization of 9-[P-(N, N-dipropyl sulfamide)] benzoylamino-1,2,3,4-4H-acridine--a potential prodrug for the CNS delivery of tacrine | Q33203874 | ||
| Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier | Q33328226 | ||
| Cell-penetrating peptides. | Q33846582 | ||
| Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications | Q33851310 | ||
| L-DOPA transport properties in an immortalised cell line of rat capillary cerebral endothelial cells, RBE 4. | Q33863661 | ||
| Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis | Q33865528 | ||
| Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice | Q33928463 | ||
| Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres | Q48388175 | ||
| Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues | Q48520331 | ||
| Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier | Q48520343 | ||
| Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method | Q48572450 | ||
| Chemical induction of fenestrae in vessels of the blood-brain barrier | Q48881084 | ||
| Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease | Q48895773 | ||
| Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain | Q49108691 | ||
| In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium | Q57677414 | ||
| Computational Approaches for the Prediction of Blood-Brain Barrier Permeation | Q58860163 | ||
| Polymeric nanoparticles for the drug delivery to the central nervous system | Q37076360 | ||
| TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors | Q37115345 | ||
| Prodrug approaches for CNS delivery | Q37150860 | ||
| Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy | Q37154213 | ||
| Progress in drug delivery to the central nervous system by the prodrug approach. | Q37193593 | ||
| Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery | Q37263021 | ||
| Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke | Q37312849 | ||
| 188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas | Q37331142 | ||
| Convection-enhanced delivery of nanocarriers for the treatment of brain tumors | Q37377024 | ||
| Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain | Q37387616 | ||
| Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases | Q37416147 | ||
| Convection-enhanced delivery in the treatment of epilepsy | Q37426998 | ||
| Delivery of peptide and protein drugs over the blood-brain barrier | Q37460463 | ||
| Transcytotic pathway for blood-borne protein through the blood-brain barrier | Q37484109 | ||
| Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. | Q38549318 | ||
| Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability | Q39428676 | ||
| Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals | Q39864437 | ||
| Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His. | Q39898999 | ||
| Nanoparticles of cationic chimeric peptide and sodium polyacrylate exhibit striking antinociception activity at lower dose | Q39915561 | ||
| Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting. | Q39915985 | ||
| Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy. | Q40020723 | ||
| Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer | Q40184020 | ||
| Interaction of nucleoside analogues with nucleoside transporters in rat brain endothelial cells | Q40498801 | ||
| Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model | Q40508031 | ||
| Pumping of Drugs by P-Glycoprotein: A Two-Step Process? | Q40627950 | ||
| Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake | Q40692947 | ||
| Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. | Q40755482 | ||
| Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. | Q41622962 | ||
| Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin. | Q41841053 | ||
| Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation | Q41905137 | ||
| Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring | Q43213074 | ||
| Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. | Q43660897 | ||
| Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model | Q43740875 | ||
| Ultrasound-induced mild hyperthermia as a novel approach to increase drug uptake in brain microvessel endothelial cells | Q44144585 | ||
| Bicarbonate-dependent depolarizing potentials in pyramidal cells and interneurons during epileptiform activity | Q44574129 | ||
| Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain | Q44766838 | ||
| The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug | Q44939144 | ||
| A strategy for delivering peptides into the central nervous system by sequential metabolism | Q45014252 | ||
| Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats | Q46253024 | ||
| Selective blood-tumor barrier disruption by leukotrienes | Q46370129 | ||
| Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting | Q46442643 | ||
| Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease | Q46740678 | ||
| Large neutral amino acid transporter enables brain drug delivery via prodrugs | Q46793172 | ||
| Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability | Q46826360 | ||
| Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier | Q46836311 | ||
| Flurbiprofen derivatives in Alzheimer's disease: synthesis, pharmacokinetic and biological assessment of lipoamino acid prodrugs. | Q46855926 | ||
| Synthesis, conformational and pharmacological studies of glycosylated chimeric peptides of Met-enkephalin and FMRFa | Q46867978 | ||
| Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs | Q47355443 | ||
| Surface modification of RGD-liposomes for selective drug delivery to monocytes/neutrophils in brain | Q48089075 | ||
| Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. | Q48096517 | ||
| Body distribution of camptothecin solid lipid nanoparticles after oral administration | Q48197933 | ||
| Determination of m-nitrophenol and nipecotic acid in mouse tissues by high-performance liquid chromatography after administration of the anticonvulsant m-nitrophenyl-3-piperidinecarboxylate hydrochloride | Q48361039 | ||
| Nanoparticulate systems for brain delivery of drugs | Q33938252 | ||
| Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery | Q33955046 | ||
| Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain | Q33966638 | ||
| ABC transporters and the blood-brain barrier | Q33978165 | ||
| Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. | Q33982544 | ||
| Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? | Q33987176 | ||
| Blood-brain barrier delivery | Q34001715 | ||
| Solid lipid nanoparticles for targeted brain drug delivery | Q34004708 | ||
| The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation | Q34207241 | ||
| Azomethine prodrugs of (R)-alpha-methylhistamine, a highly potent and selective histamine H3-receptor agonist | Q34372906 | ||
| Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability. | Q34489836 | ||
| Protein transduction technology | Q34534961 | ||
| The blood-brain barrier and cancer: transporters, treatment, and Trojan horses | Q34577796 | ||
| Multifunctional nanocarriers | Q34580225 | ||
| Progesterone for the treatment of experimental brain injury; a systematic review | Q34666646 | ||
| Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs | Q34800048 | ||
| Tat-mediated delivery of heterologous proteins into cells | Q34991904 | ||
| Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. | Q35048763 | ||
| Nasal drug delivery--possibilities, problems and solutions | Q35078394 | ||
| Convection-enhanced delivery of macromolecules in the brain | Q35091232 | ||
| Intracellular cargo delivery using tat peptide and derivatives | Q35574584 | ||
| Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts | Q35688338 | ||
| New technologies for drug delivery across the blood brain barrier. | Q35768308 | ||
| Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model | Q35800657 | ||
| Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts | Q36013320 | ||
| Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas | Q36478643 | ||
| Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA. | Q36481655 | ||
| Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas | Q36481960 | ||
| Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue? | Q36512834 | ||
| The CNS as a target for peptides and peptide-based drugs | Q36640307 | ||
| Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons | Q36732347 | ||
| Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles | Q36833069 | ||
| DP-155, a lecithin derivative of indomethacin, is a novel nonsteroidal antiinflammatory drug for analgesia and Alzheimer's disease therapy. | Q36879568 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nervous system | Q9404 |
| drug delivery | Q1392806 | ||
| P304 | page(s) | 113-135 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Expert Opinion on Drug Delivery | Q5421203 |
| P1476 | title | Various drug delivery approaches to the central nervous system | |
| P478 | volume | 7 |
| Q37788222 | Advances in using chitosan-based nanoparticles forin vitroandin vivodrug and gene delivery |
| Q35222408 | Metallofullerene-based nanoplatform for brain tumor brachytherapy and longitudinal imaging in a murine orthotopic xenograft model |
| Q36251215 | Metallofullerene-nanoplatform-delivered interstitial brachytherapy improved survival in a murine model of glioblastoma multiforme |
| Q37939942 | Nanostructure-based drug delivery systems for brain targeting. |
| Q38686370 | Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective. |
| Q37948993 | Nanotherapeutics for Alzheimer's disease (AD): Past, present and future |
| Q35003502 | Neuroimmune pharmacology as a sub-discipline of medical neuroscience in the medical school curriculum. |
| Q39157737 | Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain |
| Q35064473 | Novel central nervous system drug delivery systems |
| Q27008296 | PDE4 as a target for cognition enhancement |
| Q48265111 | Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model |
| Q35118176 | Plasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor |
Search more.